Stay updated on XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial

Sign up to get notified when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed, a minor update to the page's documentation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:37:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now shows a Locations section with Texas as a study site, and the old Texas Locations entry and the HHS Vulnerability Disclosure link were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:28:27.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now displayed, replacing Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:54:15.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The government funding operating-status notice at the top of the page has been removed.
    Difference
    0.4%
    Check dated 2025-11-17T20:09:00.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    No substantive changes to core study content were detected between the screenshots; all key elements (title, NCT number, sponsor, eligibility criteria, design, and outcomes) appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T14:24:42.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    4%
    Check dated 2025-10-06T04:35:42.000Z thumbnail image

Stay in the know with updates to XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.